We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
-18.37%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$18B
AUM Growth
-$5.4B
Cap. Flow
-$34.2M
Cap. Flow %
-0.19%
Top 10 Hldgs %
11.71%
Holding
3,640
New
900
Increased
972
Reduced
838
Closed
830

Top Buys

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$99.5M
2
SHW icon
Sherwin-Williams
SHW
+$80.5M
3
GE icon
GE Aerospace
GE
+$78.7M
4
RCL icon
Royal Caribbean
RCL
+$78.5M
5
WDAY icon
Workday
WDAY
+$74M

Top Sells

Rank Stock Value
1
SNAP icon
Snap
SNAP
+$170M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$128M
3
ZM icon
Zoom
ZM
+$120M
4
C icon
Citigroup
C
+$111M
5
AAPL icon
Apple
AAPL
+$101M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 12.5%
2 Technology 10.76%
3 Industrials 6.35%
4 Healthcare 6.3%
5 Financials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPR
2776
DELISTED
Express, Inc.
EXPR
$20K ﹤0.01%
+506
New +$30.4K
IDEX
2777
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$20K ﹤0.01%
240
-105
-30% -$9.46K
XERS icon
2778
Xeris Biopharma Holdings
XERS
$1.44B
$18K ﹤0.01%
11,651
-121,799
-91% -$257K
EFOI icon
2779
Energy Focus
EFOI
$18.3M
$16K ﹤0.01%
+1,795
New +$16.6K
OGI
2780
Organigram Holdings
OGI
$132M
$16K ﹤0.01%
4,400
-8,399
-66% -$42.8K
VTGN icon
2781
VistaGen Therapeutics
VTGN
$9.29M
$15K ﹤0.01%
564
-1,694
-75% -$59.8K
HEXO
2782
DELISTED
HEXO Corp. Common Shares
HEXO
$15K ﹤0.01%
5,018
-2,372
-32% -$11.3K
BYFC icon
2783
Broadway Financial
BYFC
$94.9M
$14K ﹤0.01%
+1,679
New +$20K
CYN icon
2784
Cyngn
CYN
$15.6M
$14K ﹤0.01%
1
-2
-67% -$57.9K
AUD
2785
DELISTED
Audacy, Inc.
AUD
$14K ﹤0.01%
+14,356
New +$28.8K
PIXY
2786
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$13K ﹤0.01%
1
RTB
2787
RTB Digital
RTB
$212M
$12K ﹤0.01%
+31
New +$29.9K
CRXT
2788
DELISTED
Clarus Therapeutics Holdings, Inc. Common Stock
CRXT
$11K ﹤0.01%
+29,085
New +$20.4K
AKBA icon
2789
Akebia Therapeutics
AKBA
$327M
$10K ﹤0.01%
29,471
-28,825
-49% -$12.1K
CNVS icon
2790
Cineverse
CNVS
$55M
$10K ﹤0.01%
1,005
-1,213
-55% -$16.3K
KUST
2791
Kustom Entertainment Inc
KUST
$846K
0
PAVM icon
2792
PAVmed
PAVM
$33.9M
$10K ﹤0.01%
+24
New +$11.6K
EMBK
2793
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$10K ﹤0.01%
1,000
-7,611
-88% -$444K
GOCO
2794
DELISTED
GoHealth
GOCO
$9K ﹤0.01%
+996
New +$11.6K
ITRM
2795
DELISTED
Iterum Therapeutics
ITRM
$9K ﹤0.01%
2,963
-8
-0.3% -$30
SDOT icon
2796
Sadot Group
SDOT
$18.5M
$8K ﹤0.01%
10
ARDX icon
2797
Ardelyx
ARDX
$1.24B
$7K ﹤0.01%
+11,364
New +$8.37K
HEPS
2798
D-Market Electronic Services & Trading
HEPS
$1B
$7K ﹤0.01%
10,884
-4,012
-27% -$5.83K
XTKG
2799
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
ECOR icon
2800
electroCore
ECOR
$51.4M
$6K ﹤0.01%
767

Similar funds

Squarepoint's Q2 2022 Portfolio in Review

As of Q2 2022, Squarepoint held 3,640 positions worth $18B, down 23% from $23.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Squarepoint's Q2 2022 filing shows 900 new, 972 increased, 838 reduced and 830 closed positions. Its largest new stake was McDonald's: 266,402 shares worth $65.8M. The largest sale was Snap, an estimated $170M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

  • Squarepoint's largest Q2 2022 buy was McDonald's: 266,402 shares worth $65.8M.
  • Squarepoint added most to CSX Corp in Q2 2022, an estimated $99.5M increase.
  • Squarepoint's biggest Q2 2022 reduction was Snap, cutting an estimated $170M.
  • Squarepoint fully exited Invesco QQQ Trust in Q2 2022, selling an estimated $128M.
  • Squarepoint's ten largest holdings make up 12% of its $18B portfolio in Q2 2022.
  • Squarepoint opened 900 new positions and closed 830 in Q2 2022.
  • Squarepoint's portfolio value fell 23% quarter-over-quarter to $18B.

Based on Squarepoint's 13F filing for Q2 2022, filed 15 Aug 2022.